Table 2.
Resource | Unit costs (2015 MXN)A | Sources and assumptions |
---|---|---|
Vaccine acquisition, cost per dose | ||
Highly effective vaccine | 321.00 | Mexican Institute of Social Security (IMSS)33 |
Moderately effective vaccine | 289.00 | Assumed 10% less than the cost of the highly effective vaccine |
Weakly effective vaccine | 260.00 | Assumed 10% less than the cost of the moderately effective vaccine |
Administration costs per dose | 18.77 | Portnoy et al.34 Incremental cost of any of the three single-dose varicella vaccines administered at the same visit as the measles-mumps-rubella vaccineB |
Cost per outpatient visit for varicella | 599.00 | Unit costs catalog 201535 |
Cost per prescription medication (for outpatient varicella case) | 4.08 | Mexican Institute of Social Security (IMSS)33 Cost data assumes the average cost of naproxen 250 mg (30 tablets) and diphenhydramine (60 mL) |
Cost per bed day (for inpatient varicella case), by age group | ||
< 1 years | 6,054.77 | Cost of hospitalization divided by average number of bed days per stay based on Mexican panel of expertsC |
1–4 years | 6,529.66 | |
5–9 years | 6,937.76 | |
10–14 years | 6,796.18 | |
15–44 years | 5,741.60 | |
45–64 years | 5,123.27 | |
≥65 years | 4,757.32 | |
Cost per herpes zoster case, by severity | ||
Without postherpetic neuralgia | 5,235.33 | Rampakakis et al.36 |
With postherpetic neuralgia | 11,290.06 |
AWhere necessary, costs were converted and/or adjusted to 2015 MXN using the web-based tool CCEMG – EPPI-Center Cost Converter.37
BCost of vaccine wastage was excluded because a single-dose vial was assumed to be used.
CAverage number of bed days per stay based on Mexican panel of experts (Merck & Co., Inc; unpublished). Detailed data shown in Supplemental Table 1.